Plasmodium falciparum SHMT: A Computational Drug Target

A computational study examined whether fosmidomycin could bind to Plasmodium falciparum SHMT, an enzyme involved in parasite metabolism. The docking workflow offers a way to explore a potential malaria drug target, while its results remain an early-stage finding rather than evidence of therapeutic effectiveness.

Read More →